arrow
K

Kawsar R. Talaat

Johns Hopkins Bloomberg School of Public Health
H指数:30
被引数:3,695

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial

mRNA COVID-19疫苗与同时或序贯接种的灭活流感疫苗的免疫原性:一项随机临床试验

Vaccine
IF3.5
2025-12-100
OAAI
Intestinal inflammation induced by heat-labile toxin-producing enterotoxigenic E: Coli infection and impact on immune responses in an experimental human challenge model

由产热不稳定性毒素的产肠毒素大肠杆菌(E: Coli)感染诱导的肠道炎症及其对免疫反应的影响:一项实验性人体挑战模型研究

2025-10-010
PRE
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews

临床免疫接种安全性评估(CISA)项目:COVID-19疫苗咨询和病例审查

Vaccine
IF3.5
2025-09-270
OAAI
Immunologic changes in the peripheral blood transcriptome of individuals with early-stage chronic Chagas cardiomyopathy: a cross-sectional

早期慢性恰加斯心肌病患者外周血转录组中的免疫学变化:一项横断面研究

2025-05-010
PRE
Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)
2024-04-030
OAAI
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers
2024-01-296
OAAI
Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older

疫苗诱导的血凝抑制抗体滴度的季节间减弱以及75岁及以上社区居住的老年人对流感的体液免疫的影响因素

2023-07-312
OAAI
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

BNT162b2新型冠状病毒肺炎疫苗在5岁以下儿童中的应用评价

2023-02-1645
OAAI
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021
2022-04-01105
OA
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
2022-01-06432
OAAI
Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination
2021-11-2836
OA
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
2021-06-22418
OA
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
2021-04-0149
OAAI